Bufu Tang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
Papers in
-
- RNA modifications and cancer 17
- Circular RNAs in diseases 8
-
- Ferroptosis and cancer prognosis 26
- Co-authors
- Jiansong Ji (27 shared papers)Jinyu Zhu (22 shared papers)Qiaoyou Weng (20 shared papers)Shiji Fang (20 shared papers)Zhongwei Zhao (14 shared papers)Liyun Zheng (15 shared papers)Chenying Lu (10 shared papers)Min Xu (10 shared papers)
- Journals
- Research (5 papers)Cancer Cell International (4 papers)Advanced Science (4 papers)Cancer Letters (3 papers)Cell Communication and Signaling (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Bufu Tang
72 papers receiving 1.8k citations
Bufu Tang's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 727
- Pulmonary and Respiratory Medicine 699
- Molecular Biology 1.1k
- Immunology 291
- Oncology 321
Countries citing papers authored by Bufu Tang
This map shows the geographic impact of Bufu Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bufu Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bufu Tang more than expected).
Fields of papers citing papers by Bufu Tang
This network shows the impact of papers produced by Bufu Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bufu Tang. The network helps show where Bufu Tang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bufu Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 170 | |
| 2 | Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Response Hit paper breakdown → | 2022 | 145 |
| 3 | 2020 | 114 | |
| 4 | 2020 | 92 | |
| 5 | 2021 | 70 | |
| 6 | 2020 | 70 | |
| 7 | 2021 | 69 | |
| 8 | 2021 | 57 | |
| 9 | 2020 | 56 | |
| 10 | Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope Hit paper breakdown → | 2024 | 53 |
| 11 | 2019 | 51 | |
| 12 | 2021 | 50 | |
| 13 | 2020 | 50 | |
| 14 | 2018 | 50 | |
| 15 | 2018 | 49 | |
| 16 | 2022 | 47 | |
| 17 | 2017 | 44 | |
| 18 | 2022 | 40 | |
| 19 | 2023 | 36 | |
| 20 | 2022 | 32 |
About Bufu Tang
Bufu Tang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Immunology, having authored 85 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (26 papers), RNA modifications and cancer (17 papers), Cancer Immunotherapy and Biomarkers (13 papers), Circular RNAs in diseases (8 papers), Cancer, Lipids, and Metabolism (7 papers), Immune cells in cancer (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (727 citations), Pulmonary and Respiratory Medicine (699 citations), Molecular Biology (1.1k citations), Immunology (291 citations) and Oncology (321 citations). Bufu Tang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jiansong Ji, Jinyu Zhu, Qiaoyou Weng, Shiji Fang, Zhongwei Zhao, Liyun Zheng, Chenying Lu, Min Xu, Minjiang Chen and Baohui Zhang. Their work appears in journals such as Research, Cancer Cell International, Advanced Science, Cancer Letters and Cell Communication and Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.